EMTC-M: Elbit Medical Technologies Ltd - Summary | Jitta

Elbit Medical Technologies Ltd

ISR:EMTC-M

Notice
Stock data is unavailable or the company’s delisted.
Price
₪0.22
Loss Chance
54.2%
2.06JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (21)
Recent Business Performance (17)
Financial Strength (31)
Return to Shareholders (2)
Competitive Advantage (18)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 59.63% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.06
100.00%
1.37
294.36%
1.37
294.36%
COMPANY DESCRIPTION
Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of therapeutic medical systems in the United States, Europe, and internationally. The company engages in developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurological disorders and tumors. It is also involved in the study and development of medical products based on stem cells originating primarily from the umbilical cord blood that are used for bone marrow transplants in the patients of leukemia or cancer of lymph nodes, non-malignant blood diseases, and metabolic genetic disorders. The company is based in Tel Aviv-Yafo, Israel. Elbit Medical Technologies Ltd is a subsidiary of Exigent Management Ltd.